Results 201 to 210 of about 166,895 (259)

Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome trial. [PDF]

Front Cardiovasc Med
Schäfer A, Großhennig A, Theis L, Schindler C, Grahl E, Stichtenoth DO, König T, Geller WA, Schmidt HHJG, Bavendiek U, Bauersachs J.   +10 more
europepmc   +1 more source

Patterned ELR‐Gelatin Hydrogels Enable Rapid Endothelial Monolayer Formation via Bioactive Matrix Chemistry and Surface Topography

Advanced Healthcare Materials, EarlyView.
Micro‐ and nano‐patterned elastin‐like recombinamer (ELR) hydrogels integrate bioactive matrix chemistry with defined surface topography. The combined cues promote rapid endothelial cell capture, alignment, and monolayer formation on soft substrates.
Jagoda Litowczenko, Yannick Richter, Martyna Michalska, Piotr Paczos, Karine Tadevosyan, Daniel Uribe, Jose Carlos Rodriguez‐Cabello, Ioannis Papakonstantinou, Angel Raya   +8 more
wiley   +1 more source

Protecting Citizens, Enabling Prevention: A Framework for Responsible Dietary Supplement Use in Europe. [PDF]

Nutrients
Cicero AFG, Borghi C, Fogacci F.
europepmc   +1 more source

Oxygels: Tunable Phosphorescent Hydrogels for Cherenkov‐Excited Luminescence Imaging (CELI) of Oxygen

Advanced Healthcare Materials, EarlyView.
Biocompatible hydrogels with covalently embedded near‐infrared phosphorescent probes enable local tissue pO2 quantification by means of Cherenkov‐excited luminescence imaging (CELI), where optical excitation occurs within tissues upon irradiation with high‐energy electron beams.
Simin Belali, Marien Iliza Ochoa Mendoza, Matthew S. Reed, Danylo Mykhalchuk, Annemarie Lang, Joel D. Boerckel, Brian W. Pogue, Sergei A. Vinogradov   +7 more
wiley   +1 more source

The Reversibility of Urate Tophi With Treat-to-Target in Gout: All Gone. Forever? [PDF]

J Rheumatol
Singh JA.
europepmc   +1 more source

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. [PDF]

Arthritis Care Res (Hoboken)
Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR.   +16 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Phosphorus-Lowering Drugs for CKD 3-5 Stages. [PDF]

Kidney Med
Hou W, Xie P, Fu Y, Wang C, Wang K, Sun Y, Wei W, Xu L, Su C.   +8 more
europepmc   +1 more source

Combining structured exercise with a low-energy diet to attenuate lean mass loss in South Asian adults living with type 2 diabetes: the COMBINE randomised trial protocol. [PDF]

BMJ Open
Arsenyadis F, Henson J, McCarthy M, Papamargaritis D, King JA, Redman E, Whelehan G, Wilkinson T, Sargeant J, Rowlands A, Boulé N, Dasgupta K, McCann GP, Davies MJ, Khunti K, Choudhary P, Yates T.   +16 more
europepmc   +1 more source

Lipid-Lowering Treatment in Familial Hypercholesterolaemia, 1996-2021: A Nationwide Study. [PDF]

Lancet Reg Health Eur
Reeh J, Wulff AB, Nordestgaard BG, Afzal S.   +3 more
europepmc   +1 more source